We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Alnylam Reports Positive Phase II Data for ALN-TTR02, an RNAi Therapeutic

News   Jul 01, 2013

 
Alnylam Reports Positive Phase II Data for ALN-TTR02, an RNAi Therapeutic
 
 
 

RELATED ARTICLES

Blood-brain Barrier Breakdown Early Marker of Human Cognitive Dysfunction

News

Individuals with early cognitive function develop brain capillary damage and blood-brain barrier breakdown in the hippocampus, regardless of amyloid beta/tau biomarker changes.

READ MORE

Researchers Pioneer Machine Learning to Speed Chemical Discoveries, Reduce Waste

News

Researchers are tapping a new set of capabilities in this field of artificial intelligence, combining artificial neural networks with infrared thermal imaging to control and interpret chemical reactions with precision and speed that far outpace conventional methods.

READ MORE

Long-sought Activator of Sigma-1 Receptors in Human Cells

News

A new study shows that choline, an essential nutrient that functions in metabolism, is an endogenous activator of sigma-1 receptors, marking an important advance in cell biology.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE